EVALUATION OF BIODEGRADABLE NANOCARRIERS FOR TARGETED DRUG DELIVERY IN HEPATOCELLULAR CARCINOMA. FMHR. 2025;3(7):1259-1272. Accessed April 23, 2026. https://fmhr.net/index.php/fmhr/article/view/1225